Korean J Med.  2003 May;64(5):588-592.

A case of hemolytic uremic syndrome developed after voluntary abortion at the sixth weeks of pregnancy

Affiliations
  • 1Department of Internal Medicine, Wonkwang university School of Medicine, Iksan, Korea. ashneph@wmc.wonkwang.ac.kr
  • 2Department of Clinical Pathology, Wonkwang university School of Medicine, Iksan, Korea.

Abstract

In 1955 Gasser and his associates describe the hemolytic uremic syndrome, which is characteristics of clinical manifestation such as microangiopathic hemolysis, thrombocytopenia, acute renal failure. The etiology of the syndrome remains unclear. Typical form of syndrome occures mainly in children in association with gastrointestinal infection or upper respiratory infection. In adults, the syndrome is seen atypically in connection with malignant tumor, pregnancy, postpartum and oral contraceptives, chemotherapeutic agent such as Mitomycin-C, immunosuppressive agent including cyclosporin. The treatment of this syndrome has remains controversial. But recently some cases were reported that plasma exchange with fresh frozen plasma has favorable improvement of prognosis in atypical syndrome. Pasquale C, Noam L have reported the case of hemolytic uremic syndrome associated with pregnancy or abortion but in Korea, such cases have not reported yet. Then we report a case of hemolytic uremic syndrome which developed after voluntary abortion at sixth weeks of pregnancy and was treated with plasma exchange with fresh frozen plasma.

Keyword

Abortion; Hemolytic-Uremic Syndrome; Plasma Exchange

MeSH Terms

Acute Kidney Injury
Adult
Child
Contraceptives, Oral
Cyclosporine
Hemolysis
Hemolytic-Uremic Syndrome*
Humans
Korea
Mitomycin
Plasma
Plasma Exchange
Postpartum Period
Pregnancy*
Prognosis
Thrombocytopenia
Contraceptives, Oral
Cyclosporine
Mitomycin
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr